Thalidomide BMS

Swiss trademark · 790073 · Word mark · In force

Register entry

Registration number
790073
Application number
10147/2022
Status
In force
Type
Word mark
Filed
Aug 2, 2022
Registered
Nov 30, 2022
Published
Nov 30, 2022
Protected until
Aug 2, 2032
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, die Thalidomid enthalten und zur Behandlung von Krebs und immunologisch bedingter Erkrankungen eingesetzt werden.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 30, 2022

    Registered

    Published in Swissreg on 30.11.2022

Parties

Holder

Bristol-Myers Squibb Company

430 E. 29th Street, 14th Floor, New York, New York 10016, US

Agent

Troller Hitz Troller, Rechtsanwälte

Schweizerhofquai 2 Postfach, 6002 Luzern

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.